Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation
- Language
-
Englisch
- Identifier
-
1211959031
Contributor
Schmid, Christoph
de Wreede, Liesbeth C.
van Biezen, Anja
Finke, Jürgen
Ehninger, Gerhard
Ganser, Arnold
Volin, Liisa
Niederwieser, Dietger
Beelen, Dietrich
Alessandrino, Paolo
Kanz, Lothar
Schleuning, Michael
Passweg, Jakob
Veelken, Hendrik
Maertens, Johan
Cornelissen, Jan J.
Blaise, Didier
Gramatzki, Martin
Milpied, Noel
Yakoub-Agha, Ibrahim
Mufti, Ghulam
Rovira, Montserrat
Arnold, Renate
de Witte, Theo
Robin, Marie
Kröger, Nikolaus
de Wreede, Liesbeth C.
van Biezen, Anja
Finke, Jürgen
Ehninger, Gerhard
Ganser, Arnold
Volin, Liisa
Niederwieser, Dietger
Beelen, Dietrich
Alessandrino, Paolo
Kanz, Lothar
Schleuning, Michael
Passweg, Jakob
Veelken, Hendrik
Maertens, Johan
Cornelissen, Jan J.
Blaise, Didier
Gramatzki, Martin
Milpied, Noel
Yakoub-Agha, Ibrahim
Mufti, Ghulam
Rovira, Montserrat
Arnold, Renate
de Witte, Theo
Robin, Marie
Kröger, Nikolaus
- DOI
-
10.3324/haematol.2017.168716
- URN
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
26.01.2023, 1:57 PM CET
Associated
- Schmid, Christoph
- de Wreede, Liesbeth C.
- van Biezen, Anja
- Finke, Jürgen
- Ehninger, Gerhard
- Ganser, Arnold
- Volin, Liisa
- Niederwieser, Dietger
- Beelen, Dietrich
- Alessandrino, Paolo
- Kanz, Lothar
- Schleuning, Michael
- Passweg, Jakob
- Veelken, Hendrik
- Maertens, Johan
- Cornelissen, Jan J.
- Blaise, Didier
- Gramatzki, Martin
- Milpied, Noel
- Yakoub-Agha, Ibrahim
- Mufti, Ghulam
- Rovira, Montserrat
- Arnold, Renate
- de Witte, Theo
- Robin, Marie
- Kröger, Nikolaus
Other Objects (12)
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation
Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia
Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5 : : a study from the Acute Leukemia Working Party of the EBMT
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Allogeneic stem cell transplantation for myelodysplastic syndrome patients with a 5q deletion
Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT
A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation
Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia
Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5 : : a study from the Acute Leukemia Working Party of the EBMT
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Allogeneic stem cell transplantation for myelodysplastic syndrome patients with a 5q deletion
Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT
A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation
Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia
Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5 : : a study from the Acute Leukemia Working Party of the EBMT
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Allogeneic stem cell transplantation for myelodysplastic syndrome patients with a 5q deletion
Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT
A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation